Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,472 | 52 | 98.9% |
| Education | $16.56 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $295.11 | 9 | $0 (2024) |
| Amgen Inc. | $256.90 | 8 | $0 (2022) |
| Fresenius USA Marketing, Inc. | $199.47 | 9 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $163.50 | 5 | $0 (2024) |
| Ardelyx, Inc. | $120.21 | 1 | $0 (2024) |
| NxStage Medical, Inc. | $79.28 | 2 | $0 (2019) |
| OPKO Pharmaceuticals, LLC | $66.40 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $62.31 | 4 | $0 (2023) |
| Keryx Biopharmaceuticals, Inc. | $58.48 | 3 | $0 (2017) |
| Mallinckrodt LLC | $52.39 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $376.77 | 8 | AstraZeneca Pharmaceuticals LP ($147.52) |
| 2023 | $151.70 | 7 | AstraZeneca Pharmaceuticals LP ($65.00) |
| 2022 | $41.24 | 2 | OPKO Pharmaceuticals, LLC ($23.53) |
| 2021 | $135.63 | 3 | AKEBIA THERAPEUTICS INC ($116.24) |
| 2020 | $18.46 | 1 | AKEBIA THERAPEUTICS INC ($18.46) |
| 2019 | $308.17 | 14 | NxStage Medical, Inc. ($79.28) |
| 2018 | $332.11 | 11 | Amgen Inc. ($146.67) |
| 2017 | $124.50 | 7 | Keryx Biopharmaceuticals, Inc. ($58.48) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Nephrology | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.70 | General |
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.91 | General |
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $117.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $120.21 | General |
| Category: NEPHROLOGY | ||||||
| 03/22/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: DIABETES | ||||||
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: NEPHROLOGY | ||||||
| 02/07/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: NEPHROLOGY | ||||||
| 02/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/16/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: NEPHROLOGY | ||||||
| 11/02/2022 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: NEPHROLOGY | ||||||
| 09/07/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Nephrology | ||||||
| 10/22/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Nephrology | ||||||
| 10/12/2021 | AKEBIA THERAPEUTICS INC | — | Food and Beverage | In-kind items and services | $96.02 | General |
| 06/07/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEPHROLOGY | ||||||
| 09/27/2019 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $20.03 | General |
| 08/13/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2019 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $20.39 | General |
| 07/25/2019 | NxStage Medical, Inc. | SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $51.50 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 532 | 1,630 | $849,508 | $260,882 |
| 2022 | 12 | 700 | 2,019 | $645,203 | $305,541 |
| 2021 | 13 | 901 | 2,752 | $773,680 | $361,707 |
| 2020 | 14 | 913 | 3,127 | $859,842 | $342,614 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 65 | 473 | $428,558 | $137,443 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 117 | 397 | $81,782 | $26,246 | 32.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 14 | 91 | $68,523 | $22,033 | 32.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 80 | 187 | $57,783 | $18,593 | 32.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 55 | $41,470 | $13,331 | 32.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 71 | 80 | $36,080 | $11,589 | 32.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 14 | 64 | $33,152 | $10,664 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 157 | $51,810 | $9,663 | 18.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 22 | $15,774 | $3,971 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 48 | $22,224 | $3,377 | 15.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $8,160 | $2,624 | 32.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 32 | $4,192 | $1,348 | 32.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 60 | 477 | $286,200 | $141,027 | 49.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 182 | 609 | $73,080 | $36,408 | 49.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 21 | 135 | $74,250 | $33,610 | 45.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 128 | 277 | $48,475 | $23,442 | 48.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 87 | 99 | $39,600 | $16,366 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 124 | $26,660 | $12,150 | 45.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 19 | 71 | $28,258 | $11,660 | 41.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 22 | 38 | $19,000 | $9,128 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 54 | $14,850 | $8,233 | 55.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 54 | 63 | $18,900 | $7,210 | 38.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 18 | 27 | $12,555 | $4,830 | 38.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 26 | 45 | $3,375 | $1,476 | 43.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 77 | 567 | $339,987 | $172,948 | 50.9% |
About Dr. Kareen Simpson, M.D
Dr. Kareen Simpson, M.D is a Nephrology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780663963.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kareen Simpson, M.D has received a total of $1,489 in payments from pharmaceutical and medical device companies, with $376.77 received in 2024. These payments were reported across 53 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,472).
As a Medicare-enrolled provider, Simpson has provided services to 3,046 Medicare beneficiaries, totaling 9,528 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Chicago, IL
- Active Since 01/16/2006
- Last Updated 11/22/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1780663963
Products in Payments
- Parsabiv (Biological) $225.69
- FARXIGA (Drug) $212.52
- XPHOZAH 30 MG (Drug) $120.21
- Velphoro (Drug) $89.44
- LOKELMA (Drug) $82.59
- SYSTEM ONE (Device) $79.28
- Auryxia (Drug) $78.70
- JYNARQUE (Drug) $67.88
- RAYALDEE (Drug) $66.40
- ACTHAR (Biological) $52.39
- Veltassa (Drug) $34.81
- AURYXIA (Drug) $28.55
- Not Product Related (Medical Supply) $25.05
- Dialyzers (Device) $21.43
- Vafseo (Drug) $18.71
- INJECTAFER (Drug) $17.78
- Parsabiv (Drug) $17.71
- JARDIANCE (Drug) $17.26
- Sensipar (Drug) $13.50
- SAMSCA (Drug) $10.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chicago
Nicole Stankus
Nephrology — Payments: $241,812
Susan Quaggin, Md, MD
Nephrology — Payments: $235,919
Lorenzo Gallon, Md, MD
Nephrology — Payments: $187,956
John Friedewald, Md, MD
Nephrology — Payments: $131,619
Arlene Chapman
Nephrology — Payments: $125,467
Dr. Jay Koyner, M.d, M.D
Nephrology — Payments: $87,521